58 related articles for article (PubMed ID: 23063289)
1. Meta analysis of gene expression changes upon treatment of A549 cells with anti-cancer drugs to identify universal responses.
Agrawal M; Gadgil M
Comput Biol Med; 2012 Nov; 42(11):1141-9. PubMed ID: 23063289
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of cancer gene-profiling data.
Yang X; Sun X
Methods Mol Biol; 2010; 576():409-26. PubMed ID: 19882274
[TBL] [Abstract][Full Text] [Related]
3. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S
Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213
[TBL] [Abstract][Full Text] [Related]
4. Integrative analysis and validation of robust gene signature in lung cancer.
Zhang XY; Zhang KT; Tian F; Xia Y; Wu YQ; Liu XJ
Biochem Biophys Res Commun; 2007 Jul; 358(3):710-5. PubMed ID: 17506981
[TBL] [Abstract][Full Text] [Related]
5. [The effect of 20(R)-ginsenoside Rg3 on the differential expression of cell signaling genes and other related genes in human lung adenocarcinoma cell line A549].
Chen MW; Yang L; Ni L; Guo X; Tian RZ; Wang XQ
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jan; 28(1):37-40. PubMed ID: 15774190
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiles for predicting the efficacy of the anticancer drug 5-fluorouracil in breast cancer.
Tsao DA; Chang HJ; Lin CY; Hsiung SK; Huang SE; Ho SY; Chang MS; Chiu HH; Chen YF; Cheng TL; Shiu-Ru L
DNA Cell Biol; 2010 Jun; 29(6):285-93. PubMed ID: 20482226
[TBL] [Abstract][Full Text] [Related]
7. Prioritizing therapeutics for lung cancer: an integrative meta-analysis of cancer gene signatures and chemogenomic data.
Fortney K; Griesman J; Kotlyar M; Pastrello C; Angeli M; Sound-Tsao M; Jurisica I
PLoS Comput Biol; 2015 Mar; 11(3):e1004068. PubMed ID: 25786242
[TBL] [Abstract][Full Text] [Related]
8. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.
Iacobuzio-Donahue CA; Ashfaq R; Maitra A; Adsay NV; Shen-Ong GL; Berg K; Hollingsworth MA; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
Cancer Res; 2003 Dec; 63(24):8614-22. PubMed ID: 14695172
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling of integrins in lung cancer cells.
Guo L; Zhang F; Cai Y; Liu T
Pathol Res Pract; 2009; 205(12):847-53. PubMed ID: 19674850
[TBL] [Abstract][Full Text] [Related]
10. Genome wide expression analysis of the effect of the Chinese patent medicine Zilongjin tablet on four human lung carcinoma cell lines.
Zhang P; Wang X; Xiong S; Wen S; Gao S; Wang L; Cao B
Phytother Res; 2011 Oct; 25(10):1472-9. PubMed ID: 21953710
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
Zhong S; Fields CR; Su N; Pan YX; Robertson KD
Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
[TBL] [Abstract][Full Text] [Related]
12. [Screening for cervical cancer-related genes and their bioinformatics analysis].
Chen SZ; Ma WL; Zheng WL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):585-8. PubMed ID: 18495597
[TBL] [Abstract][Full Text] [Related]
13. A GMM-IG framework for selecting genes as expression panel biomarkers.
Wang M; Chen JY
Artif Intell Med; 2010; 48(2-3):75-82. PubMed ID: 20004087
[TBL] [Abstract][Full Text] [Related]
14. Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas.
Bonner AE; Lemon WJ; Devereux TR; Lubet RA; You M
Oncogene; 2004 Feb; 23(5):1166-76. PubMed ID: 14647414
[TBL] [Abstract][Full Text] [Related]
15. Repression of cyclin B1 expression after treatment with adriamycin, but not cisplatin in human lung cancer A549 cells.
Dan S; Yamori T
Biochem Biophys Res Commun; 2001 Jan; 280(3):861-7. PubMed ID: 11162602
[TBL] [Abstract][Full Text] [Related]
16. Antroquinonol inhibits NSCLC proliferation by altering PI3K/mTOR proteins and miRNA expression profiles.
Kumar VB; Yuan TC; Liou JW; Yang CJ; Sung PJ; Weng CF
Mutat Res; 2011 Feb; 707(1-2):42-52. PubMed ID: 21185843
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
[TBL] [Abstract][Full Text] [Related]
18. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
[TBL] [Abstract][Full Text] [Related]
19. Alteration of miRNA profiles by ionizing radiation in A549 human non-small cell lung cancer cells.
Shin S; Cha HJ; Lee EM; Lee SJ; Seo SK; Jin HO; Park IC; Jin YW; An S
Int J Oncol; 2009 Jul; 35(1):81-6. PubMed ID: 19513554
[TBL] [Abstract][Full Text] [Related]
20. 5-Fluorouracil drug alters the microRNA expression profiles in MCF-7 breast cancer cells.
Shah MY; Pan X; Fix LN; Farwell MA; Zhang B
J Cell Physiol; 2011 Jul; 226(7):1868-78. PubMed ID: 21506117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
